Sirolimus as long-term graft-versus-host-disease prophylaxis in haploidentical hematopoietic stem cell transplant recipients for non-malignant disorders is associated with high incidence of acneiform lesions

• Huvudskapare: Aditi Chakrbarti (Författare, medförfattare), Sarita Rani Jaiswal (Författare, medförfattare), Suparno Chakrabarti (Författare, medförfattare)
• Materialtyp: Bok
• Publicerad: Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
• Ämnen: article
• Länkar: Connect to this object online.

Background: Sirolimus has provided the option for calcineurin inhibitor (CNI)-free immunosuppressive therapy in both solid organ transplant (SOT) and hematopoietic stem cell transplantation (HSCT). However, long-term use of sirolimus has been reported to be associated with a high incidence of cutane...